Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 362.69B | 339.37B | 350.67B | 300.92B | 278.44B |
Gross Profit | 119.65B | 113.93B | 119.94B | 113.54B | 115.59B |
EBITDA | 38.59B | 37.87B | 48.06B | 52.66B | 30.53B |
Net Income | 16.20B | 16.18B | 21.21B | 20.77B | 10.57B |
Balance Sheet | |||||
Total Assets | 477.59B | 437.47B | 399.17B | 362.44B | 306.92B |
Cash, Cash Equivalents and Short-Term Investments | 83.30B | 95.08B | 96.82B | 81.62B | 67.38B |
Total Debt | 65.60B | 47.80B | 44.56B | 53.75B | 43.75B |
Total Liabilities | 176.68B | 157.00B | 143.86B | 137.88B | 115.38B |
Stockholders Equity | 245.23B | 228.67B | 203.95B | 180.42B | 156.88B |
Cash Flow | |||||
Free Cash Flow | -3.99B | 9.97B | 34.86B | 1.61B | 13.19B |
Operating Cash Flow | 16.16B | 29.18B | 45.48B | 16.38B | 27.10B |
Investing Cash Flow | -41.56B | -19.99B | -10.47B | -10.40B | -6.74B |
Financing Cash Flow | 6.55B | -13.45B | -22.21B | 4.13B | -1.51B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | ¥250.03B | 15.43 | 2.42% | 6.87% | 1.26% | ||
73 Outperform | $2.94T | 15.41 | 7.40% | 2.74% | 4.38% | 13.44% | |
73 Outperform | $1.42T | 16.00 | 7.61% | 2.51% | 3.98% | 0.28% | |
68 Neutral | ¥216.11B | 20.84 | 8.21% | 2.25% | 4.80% | -0.56% | |
67 Neutral | $398.01B | 115.50 | -14.55% | 2.51% | 2.65% | -1191.54% | |
64 Neutral | $543.26B | 99.35 | 2.87% | 0.75% | 2.69% | -47.13% | |
63 Neutral | ¥1.62T | 28.47 | 4.91% | 3.64% | 9.00% | -57.41% |